Validation study of the <scp>JSHBPS</scp> nomogram for patients with colorectal liver metastases who underwent hepatic resection in the recent era ‐ a nationwide survey in Japan
Toru Beppu(Yamagata University), Keiichi Takahashi(Tokyo Metropolitan Komagome Hospital), Ken Kikuchi(Uji Hospital), Kenjiro Kotake(Tokyo Medical and Dental University), Soichiro Natsume(Tokyo Metropolitan Komagome Hospital), Itaru Endo(Yokohama City University), Tatsuro Yamaguchi(Tokyo Metropolitan Komagome Hospital), Michio Itabashi(Tokyo Women's Medical University), Goro Honda(Tokyo Metropolitan Komagome Hospital), Kiyoshi Hasegawa(Bunkyo University), Kensuke Yamamura, Katsunori Sakamoto(Ehime University), Ken Tabuchi, Yojiro Hashiguchi(Teikyo University), Kensei Yamaguchi(Japanese Foundation For Cancer Research), Masaru Miyazaki(NTT (Japan)), Satoshi Morita(Kyoto University), Kenichi Sugihara(Toujinkai Hospital), Hirotoshi Kobayashi(Teikyo University Hospital), Masakazu Yamamoto(Tokyo Women's Medical University), Yoshihito Kotera(Tokyo Women's Medical University), Shin Kobayashi(National Cancer Center Hospital East)
Cited by 34
Related Papers
Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
|New England Journal of Medicine|2010|5.6k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan
|British Journal of Cancer|2010|749
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2011|713